394 related articles for article (PubMed ID: 31136737)
21. DHT and Insulin Upregulate Secretion of the Soluble Decoy Receptor of IL-33 From Decidualized Endometrial Stromal Cells.
Salamon D; Ujvari D; Hellberg A; Hirschberg AL
Endocrinology; 2023 Nov; 165(1):. PubMed ID: 37972259
[TBL] [Abstract][Full Text] [Related]
22. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
Miller AM; Liew FY
Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
[TBL] [Abstract][Full Text] [Related]
23. The ST2/IL-33 Pathway in Adult and Paediatric Heart Disease and Transplantation.
Brunetti G; Barile B; Nicchia GP; Onorati F; Luciani GB; Galeone A
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371771
[TBL] [Abstract][Full Text] [Related]
24. Ablation of IL-33 gene exacerbate myocardial remodeling in mice with heart failure induced by mechanical stress.
Veeraveedu PT; Sanada S; Okuda K; Fu HY; Matsuzaki T; Araki R; Yamato M; Yasuda K; Sakata Y; Yoshimoto T; Minamino T
Biochem Pharmacol; 2017 Aug; 138():73-80. PubMed ID: 28450225
[TBL] [Abstract][Full Text] [Related]
25. The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target?
Aimo A; Migliorini P; Vergaro G; Franzini M; Passino C; Maisel A; Emdin M
Int J Cardiol; 2018 Sep; 267():188-192. PubMed ID: 29793758
[TBL] [Abstract][Full Text] [Related]
26. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
Willems S; Hoefer I; Pasterkamp G
Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
[TBL] [Abstract][Full Text] [Related]
27. A role for soluble ST2 in vascular remodeling associated with obesity in rats.
Martínez-Martínez E; Miana M; Jurado-López R; Rousseau E; Rossignol P; Zannad F; Cachofeiro V; López-Andrés N
PLoS One; 2013; 8(11):e79176. PubMed ID: 24265755
[TBL] [Abstract][Full Text] [Related]
28. The role of IL-33/ST2L signals in the immune cells.
Lu J; Kang J; Zhang C; Zhang X
Immunol Lett; 2015 Mar; 164(1):11-7. PubMed ID: 25662624
[TBL] [Abstract][Full Text] [Related]
29. ST2/IL-33 signaling in cardiac fibrosis.
Vianello E; Dozio E; Tacchini L; Frati L; Corsi Romanelli MM
Int J Biochem Cell Biol; 2019 Nov; 116():105619. PubMed ID: 31561019
[TBL] [Abstract][Full Text] [Related]
30. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.
Bandara G; Beaven MA; Olivera A; Gilfillan AM; Metcalfe DD
Eur J Immunol; 2015 Nov; 45(11):3034-44. PubMed ID: 26256265
[TBL] [Abstract][Full Text] [Related]
31. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
Januzzi JL; Mebazaa A; Di Somma S
Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
33. Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma.
Lee HY; Rhee CK; Kang JY; Byun JH; Choi JY; Kim SJ; Kim YK; Kwon SS; Lee SY
Exp Lung Res; 2014 Mar; 40(2):66-76. PubMed ID: 24446582
[TBL] [Abstract][Full Text] [Related]
34. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
35. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
36. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
Sweet MJ; Leung BP; Kang D; Sogaard M; Schulz K; Trajkovic V; Campbell CC; Xu D; Liew FY
J Immunol; 2001 Jun; 166(11):6633-9. PubMed ID: 11359817
[TBL] [Abstract][Full Text] [Related]
37. The IL-33/ST2 axis: Role in health and disease.
De la Fuente M; MacDonald TT; Hermoso MA
Cytokine Growth Factor Rev; 2015 Dec; 26(6):615-23. PubMed ID: 26271893
[TBL] [Abstract][Full Text] [Related]
38. Conflicting vascular and metabolic impact of the IL-33/sST2 axis.
Altara R; Ghali R; Mallat Z; Cataliotti A; Booz GW; Zouein FA
Cardiovasc Res; 2018 Oct; 114(12):1578-1594. PubMed ID: 29982301
[TBL] [Abstract][Full Text] [Related]
39. ST2 and IL-33 in pregnancy and pre-eclampsia.
Granne I; Southcombe JH; Snider JV; Tannetta DS; Child T; Redman CW; Sargent IL
PLoS One; 2011; 6(9):e24463. PubMed ID: 21949719
[TBL] [Abstract][Full Text] [Related]
40. IL-33/ST2 correlates with severity of haemorrhagic fever with renal syndrome and regulates the inflammatory response in Hantaan virus-infected endothelial cells.
Zhang Y; Zhang C; Zhuang R; Ma Y; Zhang Y; Yi J; Yang A; Jin B
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003514. PubMed ID: 25658420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
